| Publisher | Answers citing it | Answer penetration |
|---|
| consumerlab.com | 173/286 | 60.5% |
| healthline.com | 104/286 | 36.4% |
| health.usnews.com | 72/286 | 25.2% |
| amazon.com | 56/286 | 19.6% |
| gnc.com | 55/286 | 19.2% |
| walmart.com | 55/286 | 19.2% |
| straight.com | 53/286 | 18.5% |
| threeheartshome.com | 53/286 | 18.5% |
| target.com | 52/286 | 18.2% |
| cvs.com | 50/286 | 17.5% |
| bodysciencereview.com | 46/286 | 16.1% |
| consumerhealthdigest.com | 45/286 | 15.7% |
ConsumerLab.com had 60.5% answer penetration among answers with retrieval evidence. Healthline.com had 36.4%, health.usnews.com had 25.2%, amazon.com had 19.6%, and gnc.com and walmart.com each had 19.2%. The top source pattern includes health publishers, retailers, and testing or comparison material. It does not support a claim that any one source type controls all immune support answers.
Who is winning and who is at risk?
Who is winning?
Thorne is winning on broad measured appearance: it ranked first at 47.6%, appeared in all four engines, and had an average first-mention position of 2.7. NOW Foods ranked second at 44.8% and reached 84.3% in ChatGPT's 70 returned answers. Nature Made and Garden of Life shared a 39.2% appearance rate, while their engine profiles differed. Life Extension paired a 28% appearance rate with a 12.2% owned-domain citation rate among answers with retrieval evidence.
Who is at risk?
Airborne is at risk of a citation gap: it appeared in 17.5% of returned answers but had a 0% owned-domain citation rate among answers with retrieval evidence. Host Defense ranked twenty-sixth at 3.8%, with a 95% interval of 2.2% to 6.8%, and its rates stayed between 2.8% and 4.3% across engines. Emergen-C ranked eighth at 19.9%, but its average first-mention position was 7.1 and its owned-domain citation rate was 1%. Sambucol ranked twelfth at 15.7% with a 1.4% owned-domain citation rate.
What structural pattern does the tally show?
The top of the appearance leaderboard is close rather than decisive. Thorne's 41.8% to 53.3% interval overlaps the intervals for NOW Foods, Nature Made, Garden of Life, and Pure Encapsulations, so the sample does not establish that Thorne is more visible than those brands. The engines also do not converge on one stable brand set. ChatGPT repeatedly named NOW Foods and Garden of Life, Perplexity repeatedly named Nature Made, and Gemini repeatedly named certification and testing entities.
Owned-domain citation patterns are separate from appearance patterns. ConsumerLab had a 60.8% owned-domain citation rate, National Institutes of Health had 30.8%, and GNC had 19.2%, while several frequently named supplement brands had much lower owned-domain citation rates. The source list also places ConsumerLab.com, Healthline.com, health.usnews.com, amazon.com, gnc.com, and walmart.com among the cited domains. The measured answer set therefore draws support from publishers, retailers, testing sources, government material, and brand sites.
Among the brief's named brands, Host Defense was near the bottom of the measured leaderboard at 3.8%. Emergen-C, Airborne, and Sambucol appeared more often, but each had an owned-domain citation rate at or below 1.4% among answers with retrieval evidence.
What changed during the measurement window?
The data contains no time-series comparison, so it does not show a change during the measurement window. It records repeat generations across the measured prompt set and shows engine-level divergence, including Gemini's higher appearance rates for ConsumerLab, USP, NSF, and National Institutes of Health, and Perplexity's higher rates for GNC and New Chapter.
What should immune support brands fix first?
- Airborne should inspect the pages used for its immune support products because it had a 17.5% appearance rate but a 0% owned-domain citation rate. Re-measure its owned-domain citation rate across the same 24 prompts and four engines.
- Emergen-C should strengthen material that can support earlier answer placement because its average first-mention position was 7.1. Re-measure average first-mention position alongside its 19.9% appearance rate.
- Host Defense should build coverage around the specific mushroom-formula questions included in this segment because it ranked twenty-sixth at 3.8%. Re-measure its cluster results and overall appearance rate.
- Sambucol should test whether its elderberry pages can earn more retrieved support because its owned-domain citation rate was 1.4%. Re-measure citations among answers with retrieval evidence, not among all returned answers.
- NOW Foods should reduce its engine dependence because its appearance rate was 84.3% in ChatGPT but 19.4% in Claude. Re-measure each engine separately rather than relying on one combined rate.
- Nature Made should investigate its Perplexity and Claude gap because it appeared in 66.7% of Perplexity's answers and 9.7% of Claude's. Re-measure the same brand across each engine and preserve the engine-specific denominator.
- Nature's Way should standardize how the brand is named in pages and supporting material because the tally contains both Nature's Way and Nature's Way variants under the same domain. Re-measure whether those variants remain split in future answer tallies.
What does this mean for immune support brands?
Interpretation: Immune support brand visibility is not one contest with one answer. The measurement shows different answer sets by engine, while cited support often comes from testing sources, health publishers, retailers, government material, and selected brand sites. Brand teams can separate two jobs: earn brand mentions in the answers returned, and earn citations to the pages that support those answers.
For seasonal prevention, elderberry, zinc, Vitamin D, Vitamin C, and mushroom formula questions, the next measurement should preserve both distinctions. A rise in appearance without a rise in owned-domain citations would mean a different outcome than a rise in citations without broad engine coverage.
How was this immune support study measured?
This flagship study tested 24 stratified prompts three times in Perplexity (sonar-pro), ChatGPT (OpenAI), Gemini (Google), and Claude (Anthropic). It attempted 288 answers and returned 286. Appearance rates use the 286 returned answers. Citation and source rates use the 286 answers with retrieval evidence. Results are limited to the measured prompts and repeat generations on 2026-09-30.
Measurement summary
How this study was measured
- The sampling frame came first: 24 prompts were assigned across the demand clusters before any questions were asked.
- Every engine received the same questions: Perplexity (sonar-pro), ChatGPT (OpenAI), Gemini (Google), Claude (Anthropic), 3 trial(s) each.
- Of 288 attempted, 286 answers were returned, and 286 had retrieval evidence.
- Product lines were consolidated under parent brands through a registry set before scoring.
- Appearance rate uses a 95% Wilson interval; citation metrics include only answers with evidence.
The study does not measure sales, clinical effectiveness, product quality, consumer demand, or the full universe of immune support searches. It measures which named entities and cited domains appeared in this defined answer set.